Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Amplo Biotechnology, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Amplo Biotechnology, Inc.

Private

Won 5 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

Links Sign in

SAM UEI: H93DMA2RBMS1

Founded: —Source: [GOV]
Headquarters: Towson, MarylandSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 3Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Amplo Biotechnology, Inc. has been awarded 5 US Small Business Innovation Research (SBIR/STTR) contracts totalling $6,157,361 between 2021 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Towson, Maryland.

Funding rounds

6 rounds

6 rounds · latest STTR Phase II award (HHS), Mar 2025

Investors

3 on file

People

Leadership

PATRICIO SEPULVEDAPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

Amplo Biotechnology, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Amplo Biotechnology, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare

Operating status